Scientific Opinion on the substantiation of health claims related to Lactobacillus rhamnosus GR-1 (ATCC 55826) in combination with Lactobacillus reuteri RC-14 (ATCC 55845) and defence against vaginal pathogens by increasing the proportion of lactobacilli and/or decreasing the proportion of potentially pathogenic bacteria and/or yeasts (ID 945) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 6, 2011, Pages

[No Author Info available]

Author keywords

bacterial vaginosis; health claims; lactobacilli; Lactobacillus reuteri RC 14 (ATCC 55845); Lactobacillus rhamnosus GR 1 (ATCC 55826); Nugent score; yeasts

Indexed keywords

EID: 81855210201     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2232     Document Type: Note

References (18)

1. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW and Reid G, 2006. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infection, 8, 1450–1454.
2. Cadieux P, Wind A, Sommer P, Schaefer L, Crowley K, Britton RA and Reid G, 2008. Evaluation of Reuterin Production in Urogenital Probiotic Lactobacillus reuteri RC-14. Applied and Environmental Microbiology, 74, 4645–4649.
3. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F and Welling GW, 1998. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Applied and Environmental Microbiology, 64, 3336–3345.
4. Gardiner GE, Heinemann C, Bruce AW, Beuerman D and Reid G, 2002a. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clinical and Diagnostic Laboratory Immunology, 9, 92–96.
5. Gardiner GE, Heinemann C, Baroja ML, Bruce AW, Beuerman D, Madrenas J and Reid G, 2002b. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC- 14 for human intestinal applications. International Dairy Journal 12, 191–196.
6. Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, Collins MD, Thiel R, Namsolleck P, Blaut M and Dore J, 2005. Colonic microbiota signatures across five northern European countries. Applied and Environmental Microbiology, 71, 4153–4155.
7. Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y and Xiang C, 2010. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics, 11, 488.
8. Morelli L, Zonenenschain D, Del Piano M and Cognein P, 2004. Utilization of the intestinal tract as a delivery system for urogenital probiotics. Journal of Clinical Gastroenterology, 38, S107–110.
9. Ravel J, Gajer P, Abdo Z, Schneider G, Koenig S, McCulle S, Karlebach S, Gorle R, Russell J, Tacket C, Brotman R, Davis C, Ault K, Peralta L and Forney L, 2010. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences of the United States of America, 19, 8.
10. Reid G, Beuerman D, Heinemann C and Bruce AW, 2001a. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunology and Medical Microbiology, 32, 37–41.
11. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J and Henning B, 2001b. Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology, 30, 49–52.
12. Reid G, Hammond JA and Bruce AW, 2003a. Effect of Lactobacilli oral supplement on the vaginal microflora of antibiotic treated patients: Randomized, Placebo-Controlled study. Nutraceuticals & Food 8, 145–148.
13. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R and Bruce AW, 2003b. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology, 35, 131–134.
14. Reid G, Burton J, Hammond JA and Bruce AW, 2004. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. Journal of Medicinal Food, 7, 223–228.
15. Sghir A, Gramet G, Suau A, Rochet V, Pochart P and Dore J, 2000. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Applied and Environmental Microbiology, 66, 2263–2266.
16. Yamamoto T, Zhou X, Williams CJ, Hochwalt A and Forney LJ, 2009. Bacterial populations in the vaginas of healthy adolescent women. Journal of Pediatric and Adolescent Gynecology, 22, 11–18.
17. Yeung PS, Sanders ME, Kitts CL, Cano R and Tong PS, 2002. Species-specific identification of commercial probiotic strains. Journal of Dairy Science, 85, 1039–1051.
18. Zhong W, Millsap K, Bialkowska-Hobrzanska H and Reid G, 1998. Differentiation of Lactobacillus Species by Molecular Typing. Applied and Environmental Microbiology, 64, 2418–2423.